Neogen (NEOG) Cash from Investing Activities (2010 - 2026)

Neogen's (NEOG) quarterly Cash from Investing Activities came in at -$11.6 million in Q1 2026, up 64.42% year-on-year from -$7.0 million in Q1 2025, and up 0.97% quarter-over-quarter from -$11.7 million in Q4 2025.

Neogen (NEOG) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Neogen's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$11.6 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 64.42% year-over-year to -$11.6 million in Q1 2026; TTM through Feb 2026 was $58.6 million, a 158.13% increase from a year earlier, with the FY2025 full-year figure at -$99.2 million, down 238.45% from the prior year.
  • Cash from Investing Activities grew to -$11.6 million in Q1 2026 per NEOG's latest filing, from -$11.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $97.7 million in Q3 2025 and bottomed at -$33.7 million in Q3 2024.
  • The 5-year median for Cash from Investing Activities is -$11.7 million (2025), against an average of $6.7 million.
  • Across the five-year window, Cash from Investing Activities jumped 421.32% in 2022 and sank 354.84% in 2024, its largest moves.
  • Year by year, Cash from Investing Activities stood at $93.0 million in 2022, then tumbled by 87.6% to $11.5 million in 2023, then sank by 248.73% to -$17.2 million in 2024, then surged by 31.99% to -$11.7 million in 2025, then increased by 0.97% to -$11.6 million in 2026.
  • Per Business Quant, the three latest NEOG Cash from Investing Activities figures stand at -$11.6 million (Q1 2026), -$11.7 million (Q4 2025), and $97.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.36 Bn 175.06 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.86 Bn 125.99 Bn 3.81 Bn -185.00 Mn
3 Medtronic 108.02 Bn 98.80 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 68.21 Bn 66.76 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.19 Bn 44.52 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.30 Bn 27.18 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 28.02 Bn 25.74 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 24.11 Bn 20.99 Bn 2.07 Bn -475.32 Mn
10 Neogen 2.05 Bn 1.89 Bn 99.00 Mn -11.56 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 -11.56 Mn
Feb 28, 2026 -11.56 Mn
Nov 30, 2025 -11.67 Mn
Nov 30, 2025 -11.67 Mn
Aug 31, 2025 97.73 Mn
Aug 31, 2025 97.73 Mn
May 31, 2025 -15.90 Mn
May 31, 2025 -15.90 Mn
Feb 28, 2025 -32.48 Mn
Feb 28, 2025 -32.48 Mn
Nov 30, 2024 -17.16 Mn
Nov 30, 2024 -17.16 Mn
Aug 31, 2024 -33.66 Mn
Aug 31, 2024 -33.66 Mn
May 31, 2024 -17.52 Mn
May 31, 2024 -17.52 Mn
Feb 29, 2024 -14.64 Mn
Feb 29, 2024 -14.64 Mn
Nov 30, 2023 11.54 Mn
Nov 30, 2023 11.54 Mn